Patent details

Basic Information

Publication number:

EP3368534

PCT Application Number:

US2016059306

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP167944792

PCT Publication Number:

WO2017075340

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

VALBENAZINE DITOSYLATE AND POLYMORPHS THEREOF

French Title of Invention:

DITOSYLATE DE VALBÉNAZINE ET POLYMORPHES ASSOCIÉS

German Title of Invention:

VALBENAZIN-DITOSYLAT UND POLYMORPHE DAVON

SPC Number:

Dates

Filing date:

28/10/2016

Grant date:

27/01/2021

EP Publication Date:

05/09/2018

PCT Publication Date:

04/05/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/01/2021

EP B1 Publication Date:

27/01/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

28/10/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/11/2025

 

 

Name:

NEUROCRINE BIOSCIENCES, INC.

Address:

6027 Edgewood Bend Court,, CA 92130, San Diego, United States (US)

History of Owners

From:

20/01/2021

To:

20/11/2025

Name:

NEUROCRINE BIOSCIENCES, INC.

Address:

12780 El Camino Real, San Diego, CA 92130, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

10/02/2021

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

ZOOK, Scott

Address:

United States (US)

2

Name:

CARR, Andrew

Address:

United Kingdom (GB)

3

Name:

MCGEE, Kevin

Address:

United States (US)

4

Name:

BONNAUD, Thierry

Address:

United Kingdom (GB)

Priority

Priority Number:

201562249074 P

Priority Date:

30/10/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4375; A61P 25/00; C07D 471/04;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2025/13

Publication date:

04/12/2025

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

202104

Publication date:

27/01/2021

Description:

Grant (B1)

2

Issue number:

202109

Publication date:

03/03/2021

Description:

Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20250000437A

Date Registered:

20/11/2025

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

NEUROCRINE BIOSCIENCES, INC.

Address:

6027 Edgewood Bend Court,, CA 92130, San Diego, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

02/11/2026

Annual Fee Number:

11

Annual Fee Amount:

148 Euro

Expected Payer:

Last Annual Fee Payment Date:

27/10/2025

Last Annual Fee Paid Number:

10

Last Annual Fee Paid Amount:

131 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages
10/02/2021	Power Of Attorney	1
15/02/2021	Outgoing Correspondence	1
20/11/2025	Request For Change	1
20/11/2025	Outgoing Correspondence	2